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Key neuropathological hallmarks of Alzheimer’s disease (AD) are elevated levels of amyloid -peptide (A) species generated via
amyloid precursor protein (APP) endoproteolysis and cleavage by the rate-limiting -site enzyme 1 (BACE1). Because rodents do not
develop amyloid pathologies, we here investigated whether AD-like endophenotypes can be created in mice by expression of human
bace1. To avoid pitfalls of existing models, we introduced hbace1 via knock-in under the control of the CaMKII promoter into the safe
HPRT locus.
We report amyloidogenic processing of murine APP in the hBACE1 mice (termed PLB4), resulting in the formation of toxic APP
metabolites that accumulate intra- and extraneuronally in hippocampus and cortex. Pronounced accumulation of A*56 and A hex-
amers in the absence of plaque deposition was detected in brain tissue from symptomatic PLB4mice. Heightened levels of inflammation
(gliosis) also appeared in several AD-related brain regions (dentate gyrus, hippocampal area CA1, piriformandparietal cortices) at 6 and
12 months of age. Behaviorally, deficits in habituation to a novel environment and semantic-like memory (social transmission of food
preference) were detected from 3 to 4months of age. Impairments in spatial learning strategies in long-term reference (watermaze) and
working memory (Y-maze) tasks presented at 6 months, and were distinct from reductions in locomotor activity and anxiety.
Overall, our data indicate for the first time that targeted, subtle forebrain-specific expression through single gene knock-in of hBACE1
is sufficient to generate AD-relevant cognitive impairments amid corresponding histopathologies, confirming human BACE as the key
parameter in amyloid pathogenesis.
Key words: amyloid; circadian; cognition; inflammation; memory; strategy
Introduction
Alzheimer’s disease (AD), themost common type of dementia, is
characterized by progressive cognitive deficits. The generation of
amyloid  (A) species from the amyloid precursor protein
(APP), together with abnormal processing of tau, is a recognized
key event conferring toxicity and contributing to neurodegenera-
tion. Amyloidogenic endoproteolysis of APP is initiated by-site
APP cleaving enzyme 1 (BACE1), a type I transmembrane aspar-
tyl protease (Vassar et al., 1999; Cai et al., 2001). Cleavage of APP
generates a C-terminal membrane-retained fragment (CTF-) and
soluble APP (sAPP), subsequent proteolysis via -secretase re-
sults in the formation of A. Although evidence for the causative
involvement of BACE1 in human AD remains controversial (Ni-
colaou et al., 2001; Gold et al., 2003), BACE1 levels and activity
increase with age and particularly AD status (Fukumoto et al.,
2002; Yang et al., 2003; He´bert et al., 2008), thus supporting
BACE1 as an attractive therapeutic target.
A wide range of experimental studies have provided insight
into the role of BACE1 in AD pathologies. Since its discovery
(Sinha et al., 1999; Vassar et al., 1999), the impact of BACE1
deletion or partial reduction has been extensively studied
(Roberds et al., 2001): minor consequences, such as subtle
changes in anxiety and sensorimotor abilities (Kobayashi et al.,
2008), as well as enhanced long-term depression, were reported
in wild-type mice (Wang et al., 2008), whereas BACE1 manipu-
lations in APP overexpressionmodels prevented amyloid pathol-
ogy, neurodegeneration, astrogliosis, as well as cognitive deficits
(Cai et al., 2001; Luo et al., 2001, Laird et al., 2005; Ohno et al.,
2007). Rescued long-term potentiation and improved cognitive
performance were also reported after partial reduction of BACE
in 5xFAD animals (Kimura et al., 2010). Conversely, human
bace1 (hbace1) coexpression in mice carrying human appswe (Bo-
dendorf et al., 2002; Mohajeri et al., 2004) or app695 (Chiocco et
al., 2004) accelerated APP processing and the release of toxic
A40-42, sAPP, C99, and C89 terminal fragments. These find-
ings confirmed BACE1 as the key enzyme in amyloidosis and
subsequent pathologies, and suggest inhibition of this target as a
promising therapeutic strategy.
However, additional BACE1 substrates complicate the sce-
nario, with67 putative substrates identified (Gru¨ninger-Leitch
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et al., 2002; Hemming et al., 2009; Kuhn et al., 2012), though
most of cleavage products are still poorly understood. The ma-
jority of BACE1 substrates are involved in signaling (Dislich and
Lichtenthaler, 2012), e.g., regulation of cAMP/PKA signaling
(Chen et al., 2012), control of voltage-gated sodium channels
(Kim et al., 2007), and serotonergic transmission (Harrison et al.,
2003), but BACE1 is also implicated in myelin sheaths formation
of peripheral neurones and axon bundling (Willem et al., 2006).
Given the wealth of animal models (over)expressing app, tau,
and presenilin (PS1), it is somewhat surprising that no compre-
hensive assessment exists regarding the hbace1 expression per se
on AD-relevant behavioral and cellular readouts. Here, we de-
scribe a novel transgenic hBACE1 mouse based on targeted
knock-in. Our data show for the first time that human BACE1 is
crucial for the generation of AD-relevant cognitive and cellular
endophenotypes in the absence of significant plaque formation.
Materials andMethods
Animal husbandry
All animals were housed and tested in accordance with European (Euro-
pean Directive on the protection of animals used for scientific purposes;
2010/63/EU) and UK Home Office regulations, experiments were ap-
proved by theUniversity Ethics Board and performed in accordancewith
the Animal (Scientific Procedures) Act 1986.Mice were bred and housed
in positively pressured isolators at a commercial vendor (Harlan), and
delivered to our facility several weeks before testing. Animals were sub-
sequently group housed (up to 6 per cage; unless fighting between males
required isolation) in same sex cohorts in open wire-top cages with ad
libitum access to water and food at a circadian regime of 12 h (lights on at
7:00 A.M.) in a fully controlled environment (20–21°C, 60–65% relative
humidity). Behavioral testing took place during the light period (week-
days only). The holding regime was adjusted when animals were under
investigations (for details, see Behavioral analysis, below).
Generation of hBACE1 knock-in mice and genotyping
PLB4mice were generated by targeted knock-in of single copy of human
bace1 cDNA construct (hbace1, MIM 604252; GenBank accession no.
AF190725; Fig. 1A,B) on unaltered endogenous bace1/ background
under the control of mouse CaMKII promoter cloned into the HPRT
targeting vector (conducted by GenOway). The CaMKII promoter en-
sures a neuron- and forebrain-specific expression of the transgene. Gene
targeting and homologous recombination was performed in 129Ola
(E14) embryonic stem cells (in which a 35kb of the hprt gene encompass-
ing the 5 UTR up to intron 2 was deleted) and these were subsequently
injected into C57BL/6J blastocytes. Due to hprt being located on the X
chromosome, heterozygous PLB4 females were mated with transgenic
hemizygous males to generate heterozygous and homozygous females
and hemizygous males. DNA samples were prepared from tail biopsies
taken from female pups for Southern blot analysis (Fig. 1B). For confir-
mation of the presence of the recombined allele, the blotted genomic
AvrII digestion was tested with the internal 5 probe D. Results validated
the correct heterozygous status of 5 tested F1 females by detecting the 6.0
kb sized AvrII fragment of the recombined hprt allele. PLB4 offspring
were crossed with C57BL/6 mice for six generations before a homozy-
gous PLB4 linewas established.Wild-type (PLBWT) control animalswere
derived from the PLBWT line, generated via the same knock-in and
breeding regime (Platt et al., 2011).
Body weights were routinely recorded before behavioral testing, data
shown are from animals at 3 months (PLBWT: male n 12, female n
12; PLB4: male n 12, female n 20), 6 months (PLBWT: male n 20,
female n  18; PLB4: male n  20, female n  20), 9 months (PLBWT:
male n 18, female n 10; PLB4: male n 20, female n 18), and 12
months of age (PLBWT: male n 9, female n 12; PLB4: male n 10,
female n  8). Details of age, gender, and genotype of animals used for
behavioral and molecular assessments are stated below for each individ-
ual procedure.
Western blot
Mice (6months: PLBWT: n 6, PLB4: n 7; 12–14months: PLBWT: n
5, PLB4: n  6; both genders) were killed and whole brains rapidly
removed and quick frozen in liquid nitrogen. An additional transgenic
group generated via targeted knock-in, PLB1Triple mice, expressing mu-
tant happ/htau/hps1 (Platt et al., 2011) was used for comparison with
PLB4 mice (female PLB1Triple: N  4, 6-months-old). Tissues (hemi-
brains minus cerebellum and brainstem) were homogenized in RIPA
buffer, samples stored and immunoblotted, adapted from our previous
reports (Koss et al., 2013a). Here, 30 and 100 g of protein was run per
lane in NuPage 4–12% sodium Bis-Tris electrophoresis gels (15 and
18-well Novex Gels, Life Technologies) and electroblotted on Nitrocel-
lulose (0.2 m pore size; Invitrogen) membranes via the iBlot dry trans-
fer system (Life Technologies). TBST was used for wash steps and
dilution throughout the protocol (Tris buffer saline, 0.05% Tween). Fol-
lowing blocking (5%milk powder in TBST), membranes were immuno-
blotted with anti-murine N-terminal APP (1:1000, Abcam), anti-human
APP 6E10 (1:500, Covance), anti-oligomeric AMOAB-2 (1:500, Milli-
pore; Youmans et al., 2012), and anti-human BACE1 (1:500; Calbio-
chem) antibodies, applied with 5% BSA, 0.05% sodium azide, and TBST
for 24 h, followed by incubation with appropriate horseradish
peroxidase-conjugated secondary antibodies (Calbiochem; anti-mouse
or anti-rabbit at 1:5000 dilution). Three types of protein ladders were
used to guidemolecular weight reading: a broad range prestained protein
marker (for 7–175 kDa bands; BioLabs),MagicMarkXPWestern protein
standard (for 20–220 kDa bands; Life Technologies), or Novex Sharp
prestained ladder (4–260 kDa; Invitrogen). Potential changes in tau ex-
pression were assessed in tissue from 6-month-old mice (HT-7; Abcam;
1:5000, PHF-1, CP13, and MC-1 antibodies 1:100, a generous gift from
Peter Davies, Albert Einstein College of Medicine, NY). Additional
hexafluoroisopropanol (HFIP; Apollo Scientific) disaggregation experi-
ments were performed for validation of 56 kDa bands as genuine oli-
gomeric amyloid species. Here, 0, 10, and 20% HFIP was added to LDS-
and DTT-treated PLB4 and PLBWT brain homogenates (age: 6 months;
N  2 per genotype) and run with concentration of 7.5 g per lane in
10–20% Tricine gels (Novex, Life Technologies), transferred to 0.2 m
pore nitrocellulose membrane (iBlot transfer) and immunoblotted with
anti-human 6E10 antibody (1:1000; Covance). Immunoblotting signals
were visualized with enhanced chemiluminescent substrate (0.015% hy-
drogen peroxide, 30 M coumaric acid containing Tris-HCl-dissolved
1.25 mM luminal, pH 8.5). Images were captured with a Vilber-Fusion
chemiluminescence-imaging camera (Fusion Spectra Software FX). Due
to saturated signal for full-length APP using the mAPP antibody (Ab-
cam), immunoblots were truncated based on the prestained protein lad-
der and images were captured separately using exposure settings optimal
for: (1) full-length APP,(2) A*56, and (3) CTF fragments. Coomassie
Blue stain (0.1% Coomassie in 20% acetic acid and H2O) was used as a
protein loading control (Welinder and Ekblad, 2011), because potential
transgene-induced differences in traditional housekeeping proteins,
such as GAPDH or -actin, were reported previously in human AD
(Gebhardt et al., 2010) and in ADmousemodels (Eaton et al., 2013). For
validation of Coomassie staining as an alternative to housekeeping pro-
tein loading control serial dilutions of PLBWT samples were immuno-
blotted with GAPDH (Santa Cruz Biotechnology) and sequentially
stained with Coomassie (Fig. 1D). The extrapolated linear correlation
between the two methods yielded R 2  0.89 (p  0.001), validating
Coomassie Blue as a reliable loading control. Analysis of Western blots
was performed using ImageJ software; all data were normalized to the
Coomassie Blue and expressed relative to age-matched wild-type levels.
Therefore, statistical reliability was probed between age and genotype-
matched groups using two-tailed t tests.
Immunoprecipitation
Additional nonquantitative immunoprecipitation (IP) experiments
were performed to directly compare the soluble RIPA-extracted 6E10-
immunoreactive A species in PLB4 and PLB1Triple brain lysates in the
absence of depolymerizing agents. Brain tissue from a pronuclear
injection-derived APP/PS1 mouse (Borchelt et al., 1997) was used as a
positive control (soluble brain fraction). Protein G Dynabeads (Invitro-
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Figure1. Constructionofhbace1 transgene, genotypingandexpressionanalysis of PLB4mice.A, Schematic representationof the “Quick knock-in” strategy. Grayboxes represent exons. Solid line
represents intronic sequence. Purple and blue rectangles represent CaMKII and hbace cDNA, respectively. The red rectangle represents the hprt promoter. B, Southern blot results from the F1
generation. The genomic DNA samples of the tested F1 mice were compared with WT DNA (C57, E14). The 5 digested DNAs were blotted on nylon membrane and hybridized with the 5 probe D
to validate zygocity of the hprt knock-in mutation in these animals (7.9 kb band: WT hprt allele, 6 kb: recombined hprt allele). C, Body weights of transgenic animals (Figure legend continues.)
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gen) were conjugated to 6E10 IgG (1.5 g beads;10 g 6E10), cross-
linked by 5mMBis(sulfosuccinimidtyl)suberate (BS3) and quenched in 1
mMTris HCl, before the addition of 200l forebrain homogenates (pre-
pared as above). Following a 10min incubation period, immunodepleted
samples were removed and the target antigen eluted in 50mMglycine, pH
2.8. 6E10 antigen enriched samples were then prepared in loading buffer
(as above) and 10 l of the resulting preparation were run alongside
similarly treated immunodepleted samples. Tricine gels (10–20%, Life
Technologies) were used for electrophoresis and immunoblotting was
performed as described above (0.2 m pore nitrocellulose membrane,
iBlot transfer).
Immunocytochemistry
Animals (6months of age: PLBWT: n 4, PLB4: n 4; 12months of age:
PLBWT: n 4, PLB4: n 6; all mixed gender) were perfused transcardi-
ally with 0.9% NaCl (saline), pH 5.5, followed by 4% paraformaldehyde
(Sigma-Aldrich) in PBS. The brains were fixed, wax embedded, sec-
tioned, prepared, and stained as described previously (Koss et al., 2013b).
For regional inflammatory expression brains were sectioned from
bregma3.0 mm to2.5 mm to obtain several areas of interest: caudal
and rostral hippocampi, amygdala (Am), parietal (Pt), and piriform (Pir)
cortices. Primary antibodies used were rabbit anti-hBACE1 C-terminal
(Calbiochem; 1:200 dilution), anti-APP/-amyloid antibody (6E10, Co-
vance; 1:200 dilution), andmonoclonal preconjugated GFAP-Cy3 (Glial
Fibrillary Acid Protein, Sigma-Aldrich; 1:400 dilution). Primary anti-
bodies were visualized with Bonds refined DAB staining kit (Leica Mi-
crosystems) or appropriate AlexaFluor 488 secondary antibodies
(Invitrogen; goat anti-rabbit, 1:250). Nuclei were counterstained with
either hematoxylin or DAPI (Prolong Gold with DAPI, 4,6-diamidino-
2-phenylindole dihydrochloride; Sigma-Aldrich). Immunohistochemi-
cal images were captured with a digital camera (Axiocam, Carl Zeiss)
mounted on a Zeiss microscope (Axioskop 2 Plus) with water-
immersion lens (10, 40, or 100) or confocal microscope with oil-
immersion lens (63, LSM700; Zeiss).
Quantification of regional (CA1, dentate gyrus, DG; parietal associa-
tion cortex) immunoreactivity to 6E10was performed using Fiji software
(APP-positive cell counting), data were normalized to the total number
of cells present in a region of interest (ROI) and expressed relative to
wild-type (WT). Analysis and quantification of activated astrocytes, or
extracellular APP labeling was performed using ImageJ software, and
expressed as area stained (in percentage). Stereologically matched brains
sectionswere analyzed (3–5 per animal), and all data expressed relative to
WT. The sizes of ROIs were as follows: 600 800 m for hippocampal
and 800  800 m for cortical areas. Additional histological analyses
were performed to determine levels of astroglyosis for specific learning
phenotypes of 12-month-old PLB4 mice assessed in the open field water
maze. “Good” and “bad” learners (N 3 per group) were chosen based
on the highest deviation from the mean cognitive score (sum of path
length during training days 1–4; mean score  26.2 m; good learners:
mean 18 m, bad learners: mean 	30 m). Statistical reliability was
probed using two-way ANOVAs (learning phenotype brain region) or
t tests for data from age- and genotype-matched cohorts.
Behavioral analysis
Motor performance and motor learning (RotaRod). Two automated four-
lane accelerating RotaRods (Model 33700-R/A; TSE; Robinson et al.,
2012) were used to examine motor coordination and motor learning in
6-month-old animals (PLBWT: male n  9, female n  10; PLB4: male
n  10, female n  10). Testing consisted of four trials per day for 2
consecutive days with intertrial intervals of 2–3 min. Each mouse was
placed on the rotating rod, which accelerated from 1 to 45 rpm over the
trial time of 5 min. Trials were terminated when animals fell off (or the
maximum time was reached) and latency to descent (in sec) served as an
indicator of motor coordination (linearly correlated with rotations sus-
tained). Animals were allocated to lanes on different days following a
Latin square design to counterbalance rod position and time of testing.
Gait analysis (CatWalk). Gait analysis was performed on the same
cohort of 6-month-old mice (see RotaRod; PLBWT: male n  9, female
n 10; PLB4: male n 8, 1 excluded, female n 10) using the CatWalk
apparatus (Noldus IT; CatWalk XT 8.1; Robinson et al., 2012). The ap-
paratus consisted of an illuminated glass walkway and under-floor cam-
era to record individual footprints. Mice were given three trials and a
maximum time of 5 s each to traverse the glass plate and only one trial
was used for analysis. Recorded data included the relative position, tim-
ing, pressure, and dimensions of each footfall. Parameters analyzed com-
prised step regularity, base of support (width between left and right paw),
stride length in front and hindpaws, and a regularity index (percentage of
occurrences of the 4 most frequently used footfall patterns).
Circadian activity and habituation to a novel environment (Pheno-
Typer).Locomotor and circadian activity patternswere assessed inmixed
gender cohorts at 3 months (PLBWT: n  11, PLB4: n  13), 6 months
(PLBWT: n 10, PLB4: n 14), and 12 months of age (PLBWT: n 12,
PLB4: n  19), using a PhenoTyper homecage system (Noldus IT) as
described previously (Platt et al., 2011; Robinson et al., 2013). Ambula-
tory activity was continuously registered through infrared-sensitive cam-
eras and tracked at 12.5 samples/s for 7 consecutive days using the
multiarena module of Ethovision 3.1Pro software (Noldus IT). Parame-
ters analyzed included distance moved as the main dependent variable
for activity; we also explored the time spent in the food zone as a proxy for
overall food intake (Riedel et al., 2009; Robinson et al., 2013).
Habituation to the new environment (first 3 h of recordings on day 1)
served as an indicator of exploratory behavior and the animals’ capability
to create a spatial representation of their environment (Vianna et al.,
2000). Data were extracted in 10min bins and analyzed using a one phase
decay fit to graphically track habituation curves of both PLBWT and PLB4
animals. Initial novelty-induced exploration (Y0), time constant (tau),
and plateau (stable y-axis level; i.e., activity; Robinson et al., 2013) were
calculated; note that the decline in activity occurs at the rate constant K
(inverse of tau) and is a proxy for the speed of the habituation.
Data for days 3–7, i.e., when animals were fully habituated to the cages,
were transformed by our in-house software (Mnimi) and results aver-
aged into (1) hourly bins over 4 d (94 h) and (2)means for 12 h light/dark
phase. Ambulation was analyzed using a two-way ANOVA (genotype
and time as factors) with repeatedmeasures; habituationwas analyzed by
nonparametric statistics. Alpha was set to 5%.
Anxiety
Light/dark box. Anxiety behavior in the light/dark box (LDB) was as-
sessed at 6 months of age (PLBWT: n 11, PLB4: n 12; mixed gender).
The LDB apparatus was constructed according to Crawley and Goodwin
(1980) and consisted of two Perspex boxes: a big open white compart-
ment (30 30 30 cm) brightly illuminated by a 60 W desk lamp (550
lux); and a smaller dark compartment (30 20 25 cm) covered with
4
(Figure legend continued) were recorded at 3, 6, 9, and 12months (m). Although body weights
of transgenic mice were unaltered at 3 months, male PLB4 mice showed marked reduction in
body mass at 6, 9, and 12 months of age, compared with age-matched control group. Female
PLB4 showed similar trends and present with significantly decreased weights at 12 months of
age. D, Validation of Coomassie staining as an improved alternative to housekeeping protein-
loading controls. Western blot image from 12-month-old PLBWT brain homogenates run at
varying protein concentrations (1–25 g/lane). Resulting nitrocellulose membranes were
stained with the traditional housekeeping protein GAPDH (1:10,000), followed by Coomassie
protein stain. Linear regression analysis fromWThomogenates yielded a strong correlation (R 2
 0.89) between densitometrymeasures of GAPDH and the total protein detected by Coomas-
sie. E, Representative Western blots verify hBACE1 protein (70–75 kDa) expression in brain
tissue of PLB4 animals stained with anti-human BACE1 specific antibody. F, Western blot ex-
amples comparingmale and female expression levels.G, Quantitative hBACE1 analyses in PLB4
compared with nontransgenic animals at 6 and 12 months of age (n 6 each) confirmed
significantly increased levels of hBACE1 inPLB4brains, nodifference in expressionwasdetected
betweenmales and females (H). I, Confocal images of hBACE1 immunoreactivity in PLBWT and
PLB4brain tissue at 6months of age. hBACE1 (visualizedwithAlexaFluor 488; green) staining in
DG, CA1 and cortex (CTX) was particularly intense at neural somata (nuclei indicated by DAPI;
blue) and absent from astrocytes (GFAP; red). Negative control (ve ctrl) images represent
PLB4 tissue sections from secondary antibody control staining. Scale bar, 50m.Magnification
63. All data represent mean SEM. Asterisks indicate difference to the control group;*p
0.05, **p 0.01, ***p 0.001.
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Plexiglas lid (5 lux). The compartments were connected by an aperture at
floor level. Animals were individually placed in the brightly lit compart-
ment facing the opening and allowed to freely explore the apparatus for
10 min. Time spent in the dark compartment and motor activity (dis-
tance moved, video-tracked using Ethovision in the light compartment)
were taken as indicators of anxiety and exploration, respectively. Dis-
tance moved was normalized compared with time spent in the light
compartment to compensate for unequal durations in zones, i.e., activity
data are expressed as mean centimeters per minute.
Elevated plus maze. Fear-related phenotypes were examined further in
the elevated plusmaze (EPM; Pellow et al., 1985) using a different cohort
of animals at 6 months of age (PLBWT: n  11; PLB4: n  11; mixed
gender). The EPM consisted of a gray cross-shaped Perspex apparatus
(arms: 35 cm long 5 cmwide; central square: 5 5 cm). Two opposite
arms were delimited by vertical walls (closed arms), and the other two
had unprotected edges (open arms). The apparatus was elevated 42 cm
above the laboratory bench, in a dimly illuminated room (light intensity
in open arms: 95 lux; in closed arms: 28 lux). At the start of the 5min trial,
each mouse was placed in the central square of the maze facing an open
arm. Visits to open and closed arms and the frequency of open arm
entries were recorded by an overhead camera (Ethovision software).
Time spent in open arms and distance moved served as measures of
anxiety and exploratory behavior.
Spatial working memory: the Y maze
Spontaneous spatial alternation was assessed at 3 months (PLBWT: n 
13; PLB4: n  14), 6 months (PLBWT: n  11; PLB4: n  13), and 12
months of age (PLBWT: n  15; PLB4: n  20) with mixed gender co-
horts. Animals were placed individually into the Y maze (60 10 10
cm) and allowed to freely explore the apparatus for 10 min. The activity
of the subjects was recorded by an overhead camera and tracked by
Ethovision. The number of correct alternations as well as the alternation
index (in percentage) based on triplet combinations (i.e., ABC) served as
main indices of spatial workingmemory. The total number of transitions
and distance moved were taken as proxies for overall activity.
Spatial reference memory: the open-field water maze
Spatial memory in the open-field water maze (OFWM) was assessed
using a 150-cm-diameter and 50-cm-high white Perspex pool, filled with
water (21
 1°C) and surrounded by several fixed room cues visible from
the pool (Platt et al., 2011; Ryan et al., 2013). Animals (mixed gender: 6
months, PLBWT:n 14; PLB4:n 14; 12months, PLBWT:n 14; PLB4:
n 19)were allocated to target platform locations (rising platforms;Ugo
Basile) and released from four different sites (S, W, N, E), with a maxi-
mum swim time of 90 s. Following visible platform training [for 1 d, 4
trials, 30min intertrial interval (ITI), curtains drawn], four training days
commenced with a submerged platform (no curtains drawn). Mice re-
ceived four trials each day (ITI: 30 min) and swim paths to platform
(acquisition time on platform: 30 s) were recorded and tracked online
(Any-Maze software, Ugo Basile). Standard parameters analyzed includ-
ed: (1) path length to platform and (2) swim speed to determine spatial
cognition and activity parameters, respectively. After the last trial (delay:
1 h), the platforms were lowered and a probe trial (60 s) was performed.
Here, the time spent in the target quadrant was determined.
Classification of search strategies
Acquisition learning of the platform location in the water maze typically
involves the progressive improvement toward more spatially accurate
swim paths. These have been identified previously (Wolfer and Lipp,
2000; Gil-Mohapel et al., 2013) and applied to the analysis of spatial
learning in ADmice (Janus, 2004; Brody and Holtzman, 2006). We here
developed a MATLAB (MathWorks) script of strategy selections and
hierarchical priorities based on the description byGarthe et al. (2009). Its
translational value was recently confirmed in a human study using a
virtual water maze analog (Schoenfeld et al., 2010). In total,	1300 swim
tracks were analyzed and classifications visually confirmed by two unbi-
ased experimenters for one of the following eight strategies: (1) Wall
hugging (persistent swimming along the periphery, 35%, of the pool),
(2) random search (swim path coveringmost of the pool in wide circles),
(3) scanning (search path restricted tomainly the center of the pool), (4)
chaining (circular swimming in clockwise or anticlockwise fashion at a
distance from wall matching the distance of the platform location), (5)
directed search (directional triangular swimming from release site to
target), (6) focal search (direct swim to platform vicinity followed by
focal searching in a small radius surrounding the target), (7) direct swim
(straight swim and climbing onto platform), and (8) any other swim
pattern not falling into the categories above. As the latter category was
rare (2% of total swims) in all genotypes and ages, they were not con-
sidered here. During acquisition of the spatial location of the submerged
platform, animals progress through these categories and become more
spatially oriented. To avoid misclassifications, a hierarchical search was
implemented such that spatial strategies were interrogated first. After
each trial was categorized into one of the above search patterns, we es-
tablished daily means (in percentage) per group. Finally, we explored
path efficiency based on pixel analysis of the path for each swim strategy,
calculated as E (hypothetical perfect path/total recorded path) 100.
As a result, values scatter between 100 (perfect trial) and 0 (platform not
found).
Semantic memory: social transmission of food preference
A semiautomated version of the Social Transmission of Food Preference
(STFP) test was developed in our laboratory, based on the principles laid
out by Galef and Wigmore (1983). In this task, a food bias of an “ob-
server” animal is induced via social interaction with a “demonstrator”
mouse (previously exposed to distinctly flavored food); olfactory mem-
ory is subsequently interrogated in a food preference test. STFP was
assessed in animals kept in PhenoTyper home cages at 4months (PLBWT:
n  11; PLB4: n  21; mixed gender) and 6–7 months of age (PLBWT:
n  22; PLB4: n  22; mixed gender). Animals were habituated to the
novel environment for 3 d with ad libitum access to food pellets and
water. Following habituation mice were exposed to ground mouse chow
in jars located in corners for a period of 24 h (habituation and determi-
nation of subject’s spatial preference for food jar location). Before test-
ing, animals were food deprived overnight (16 h). On the following
morning, the demonstratormice were exposed to novel food flavors (1%
cinnamon-mixed chow or 2% cocoa-mixed chow) for 30 min and sub-
sequently placed in a social interaction cylinder (8 cm in diameter, 20 cm
tall) positioned in the PhenoTyper cage allowing the observermice social
interaction (SI) with the demonstrator. This SI phase was recorded for 30
min (simultaneous recordings of 24 animals in individual cages) and
interaction measured as time spent and distance moved by the observer
in the interaction zone (4 cm around the cylinder). Subsequently, the
demonstrator mice were removed and following a delay of (1) 15 min
(short-term memory test; STM), and (2) 24 h (long-term memory test;
LTM), observer mice were exposed to two jars containing novel flavors
(1% cinnamon-mixed chow and 2% cocoa-mixed chow). Jars with cor-
rect (matching flavor of demonstrator) food flavor were placed in the
least preferred corners to avoid a spatial bias. The activity of the subjects
during the food preference test was recorded for 30 min for STM or 12 h
for LTM, with no further food deprivation between recordings. Prefer-
ence for correct food (as percentage of total food intake), as well as food
intake (in grams, correct vs incorrect) were taken as main indices of
intact semantic memory. Other parameters analyzed for the test phase
were time spent (sec) and frequency of visits to the food jars and jar
vicinity zones, and overall distance moved (cm).
Statistics
Statistical analyses were performed with Prism (V.5 GraphPad) using
ANOVA (one- or two-way, as appropriate) followed by suitable post-
tests. Data from more than one trial or time point (Weight, RotaRod,
PhenoTyper, OFWM) were probed using repeated-measures (RM) two-
way ANOVA (time  age or genotype as factors). Comparisons to the
levels of chance using Wilcoxon signed-rank test are also reported
(chance values: Y-maze alternation index: 33.33%; STFP: 50%, water
maze probe trial: 25%). For detailed analysis of water maze strategies,  2
analysis was conducted on the relative frequencies of occurrence between
age groups of identical genotypes over 4 d, and between genotypes at the
same age for the final day of acquisition learning. Individual data pairs
were tested with paired or unpaired t tests as appropriate. For all proce-
dures, p 0.05 was considered reliable.
10714 • J. Neurosci., August 6, 2014 • 34(32):10710–10728 Plucin´ska et al. • Human BACE Knock-In Reiterates Alzheimer’s
Results
Molecular and immunohistochemical confirmation of
gene expression
Successful insertion of the transgene (Fig. 1A) was confirmed by
the presence of the 6.0 kb sized AvrII fragment of recombined
hprt allele in heterozygous PLB4DNAextracted from tail samples
using Southern blot analysis (Fig. 1B); this was absent in corre-
sponding WTs.
Human BACE1 protein expression in PLB4 animals was deter-
mined via Western blot analysis of cell lysates prepared from brain
extracts (Fig. 1E–G) and quantified based on the Coomassie Blue
method, validated versus GAPDH in PLBWT samples (Fig. 1D).
Somecross-reactivitywithmouseBACE is suggestedby thepresence
of faint bands in PLBWT samples, however, BACE levels were1.8-
fold and2.2-fold higher in transgenic mice compared with non-
transgenic controls at 6 and 12 months of age, respectively (all p
0.01; Fig. 1G). Bands detected at 70–75 kDa are indicative of the
mature (glycosylated) form of the protein (Cole and Vassar, 2007).
Further analysis revealed no effects of gender on levels of hBACE1
protein expression (p 0.12; n 5 per gender; Fig. 1H).
Immunofluorescent labeling for hBACE1 in the hippocampus
of 6- and 12-month-old mice (Fig. 1I; examples shown are from
DG, CA1, and parietal cortex), double-labeled for astrocytes
(GFAP), further confirmed hBACE1 expression in forebrain ar-
eas of PLB4 animals, in agreement with the CaMKII promoter
profile (Odeh et al., 2011). The lack of overlay comparing glial
with BACE labeling verified the predominantly somatic hBACE1
immunoreactivity in neurones with staining largely absent from
astrocytes. Strongest labeling was detected in the DG. PLBWT
brain tissue exhibited again very low but apparent levels of im-
munoreactivity to the hBACE1 antibody, indicative of some spe-
cies cross-reactivity due to the close homology of mouse and
human BACE1 (Sambamurti et al., 2004).
Breeding and general health
Breeding, litter size, overall health, and attrition rates were not
altered in PLB4 compared with PLBWT mice. Body weights of
transgenic animals did not differ at 3 months of age compared
with control animals (F 1, p	 0.05), but pronounced effects of
genotype were detected from 6 to 12 months of age indepen-
dently of gender (two-way ANOVA, males: F(1,104) 29.61, p
0.001; females: F(1,80)  14.29, p  0.001; Figure 1C). Interest-
ingly, closer inspection revealed that whereas female PLB4 mice
sustained normal body mass until 9 months of age (marked re-
ductions in body weights at 12 months of age; Bonferroni post-
test: p  0.001), male PLB4 animals were significantly lighter
than theirWT controls from 6month of age onward (Bonferroni
post-tests, 6 months: p  0.05, 9 months: p  0.01, 12 months:
p  0.01). Notably, in contrast to PLBWT there was no further
weight gain in PLB4 mice from 6 to 12 months of age indepen-
dent of gender (ranging from 35.5–37 g and 29.5–32 g on average
in males and females, respectively), thus leading to significantly
lower body weights in the older PLB4 cohorts.
Behavioral changes and cognitive deficits in PLB4 mice
Intact motor coordination and gait
Motor performance tests using the RotaRod suggested that there
was no difference in untrainedmotor coordination (measured as
mean of the two initial trials,
SEM, PLBWT: 40.5
 2.8 s; PLB4:
34.4
 3.9 s; t 1.3, df 2, p 0.33, two-tailed t test). Similarly,
motor learning recorded over eight trials did not differ between
genotypes (F(1,259) 1.6; p 0.2; Fig. 2A), but therewas a reliable
trial effect (F(7,259)  17.3; p  0.0001) confirming improve-
ments in the ability to master the task. Although some minor
differences appear (Fig. 2A), a gender comparison did not yield
any reliable anomalies in the PLB4 cohorts (all F 1.3).
The same animals were also tested for their gait using the
CatWalk paradigm. Although there was no genotype effect for
base of support (F(3,64) 1.8, p 0.15), the width between front
paws was considerably smaller in both genotypes and genders
relative to hindpaws (Fig. 2B; F(3,64) 90.5; p 0.0001). Also, the
regularity index as a proxy for the two most frequently expressed
cruciate and alternate foot print patterns showed no phenotype
or gender effect (Fig. 2C; F  3; p 	 0.05), but the stride length
was significantly reduced in PLB4 mice (Fig. 2D; genotype/gen-
der: F(3,139) 22; p 0.001) with no difference between front or
hindpaws (F(1,139)  2.3; p  0.13). Overall, data reveal minor
differences in gait in PLB4 mice not congruent with a severe
motor phenotype in this transgenic model.
Delayed habituation and global reduction in ambulatory activity
in PLB4 mice
Analysis of habituation (i.e., the first 3 h of recordings) as an
index for nonassociative learning revealed an overall significant
difference between genotypes at all age groups as well as an inter-
action with time bin (F	 6, p 0.0001; Fig. 3A–D). At all ages,
PLB4 mice were more active than PLBWT and presented with a
reduced slope during habituation. Subsequent analyses of activity
patterns within a given age group yielded a strong trend at 3
months (F(1,374)  4; p  0.052) and reliable differences at 6
months (F(1,374) 8.4; p 0.01) and 12months (F(1,510) 5; p
0.05; Fig. 3A–C).Higher levels of activity and delayed habituation
in PLB4 groups was mathematically fitted to a nonlinear expo-
nential decay function (Robinson et al., 2013) which corrobo-
rated the results of the activity data (all F 	 14, p  0.0001).
Interestingly, there were no differences in initial (Y0) or pla-
teau activity between genotypes and ages, but an extended
half-life of the decay (tau time constant) emerged for PLB4 at
all ages (Fig. 3D).
A strong aging effect was detected in PLB4mice during habit-
uation (effect of age: F(2,731)  5.9; p  0.01; interaction effect:
F(34,731) 3.5; p 0.001; Figure 3D), whereas no similar trends
were observed in PLBWT (F 3, p	 0.05). Overall, this pheno-
type is strong support for the notion that there is no overall
movement deficit in PLB4 mice, but reduced cognitive process-
ing during habituation (Robinson et al., 2013).
Circadian activity in habituated animals (distance moved in
hourly bins for a total of 4 consecutive days at all age groups; Fig.
3E–G) analyzed with a two-way RM ANOVA [genotype/age as
between-subject and time (bin) as within-subject factor] attained
an effect of genotype/age (F(5,6789) 5.5; p 0.001), an effect of
time (F(93,6789)  35; p  0.0001), as well as an interaction
(F(465,6789)  2.6; p  0.0001). Further analyses within the indi-
vidual age groups substantiated that PLB4 animals at the age of 3
months did not differ from PLBWT (F  1, Fig. 3E) and both
genotypes showed the C57BL/6-typical circadian pattern with
nocturnal activity peaks. At 6 months of age (Fig. 3F), circadian
rhythms were maintained, but motor activity of PLB4 animals
was drastically reduced (F(1,2046)  26.6, p  0.0001); a similar
comparison at 12 months showed a trend but did not attain reli-
ability (F(1,2697)  3.3, p  0.08; Fig. 3F) possibly due to a pro-
gressive reduction in activity in PLBWT. Data pooled for light/
dark phase further confirmed the decrease in locomotor activity
of PLB4 mice at 6 months (F(1,22)  26, p  0.001) during both
light (p 0.05) and dark periods (p 0.001; Fig. 3H).
Plucin´ska et al. • Human BACE Knock-In Reiterates Alzheimer’s J. Neurosci., August 6, 2014 • 34(32):10710–10728 • 10715
No age effect was obtained in PLBWT mice but an interaction
emerged between age and phase (3, 6 and 12 months groups,
two-way ANOVA, effect of age: F  1, p 	 0.05; interaction:
F(3,41) 3.66, p 0.05), whereas a robust age-dependent change
in activity was detected in the transgenic group (effect of age:
F(2,43)  9.5, p  0.001; interaction: F(2,43)  13.9, p  0.001),
which was particularly apparent during the dark phase at both 6
and 12 months compared with 3 months (Fig. 3F,G).
As a follow up to the reduced bodymass observed in PLB4mice
(Fig. 1C), further analysis of time spent in the foodzoneas ameasure
for food intake (Riedel et al., 2009) was investigated. Here, the time
spent inboth foodandwater zones at 3, 6, and12monthsof agewere
not found to differ between PLB4 mice and age- and gender-
matched controls (F 1, p	 0.05; data not shown).
Alleviated anxiety and exploratory phenotypes in
novel environments
As evidence for activity changes was uncovered in PLB4 mice
from 6months of age, we further investigated fear-related behav-
iors as putative confounding factors in this age group. Both the
LDB and EPM suggested an anxiolytic phenotype of PLB4 mice.
In the LDB, PLB4 animals remained significantly longer in the
light compartment (Fig. 4A; p  0.03), and a corresponding
strong trend (time in open arms) was also observed for the EPM
paradigm (Fig. 4B; p  0.08). Total distance moved revealed
trends for increased exploration in the EPM (Fig. 4C; EPM: p
0.08), while activity in the LDB (corrected for the time spent in
the lit compartment) was not altered (p 	 0.05) in PLB4 mice.
Representative activity traces obtained during the LDB and EPM
testing are shown in Figure 4D.
Spatial working memory deficits in PLB4 mice emerge at 6 months
of age
Because non-associative learning was deficient at 6 months of
age, we also examined spatial working memory performance in a
spontaneous alternation task in the Y-maze. Based on the global
alternation index (Fig. 5A) we observed a significant interaction
between genotype and age as factors (F(2,80) 4.2; p 0.05). This
was due to deficient alternations in PLB4 animals at 6 months of
age (t  2.52, p  0.01), but there was no difference compared
with PLBWT at 3 or 12 months. Closer inspection suggests that
this effect was ultimately caused by an improved performance of
controls at 6 months of age. It is likely that the overall higher
activity in both genotypes at 3 months of age, indicated by total
number of transitions, impacts on alternation behavior, as con-
firmed by the significant effect of age (F(2,80)  21.2, p  0.001;
Fig. 5B). At 6 and 12 months of age, we noted trends for elevated
locomotor activity (distance moved) of PLB4 mice compared
with wild-type (p  0.08 and p  0.1, respectively; data not
shown), confirming an exploratory phenotype of our hBACE1
transgenic mice (Fig. 3A).
hBACE1 expression decreases spatial precision in the OFWM
Next, cognitive performance was evaluated in the OFWM. The
length of the swim path in the visual platform trials did not differ
between genotypes at any age (p	 0.05; data not shown). How-
ever, reliable age- and genotype-related deficits in spatial acqui-
sition were obtained with increased path length to find the
hidden platform in PLB4mice. This was significant at both 6 and
12 months of age (two-way RM ANOVA; genotype effect at 6
months: F(1,78) 4.34, p 0.05; 12 months of age: F(1,93) 4.5,
Figure 2. Motor coordination and gait assessments in 6-month-old PLBWT and PLB4 mice. A, Latency of descent from RotaRod was unaffected in hBACE1 mice (no overall genotype effect) and
both PLBWT and PLB4 mice displayed intact motor learning. B, Analysis of gait in the CatWalk test confirmed intact motor function of PLB4 mice, with preserved base of support in both front and
hindpaws, and (C) step regularity.D, Bothmale and female hBACE1mice presentedwith decreased stride length comparedwith gender-matched PLBWT controls. All data representmeans
 SEM.
ns, Not significant; ***p 0.01.
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p  0.05; Figure 6A and B, respectively). No effect of age was
uncovered for either genotype (F 1). Planned post hoc analyses
for the performance on the last day suggested that 6-month-old
PLB4mice did not reach the same level of performance compared
with age-matched PLBWTmice (p 0.05). This also resulted in a
genotype effect uncovered for the probe trial, where the younger
age group spent less time in the target quadrant (overall genotype
effect: two-way ANOVA with genotype and age as factors: F(1,58)
 4.5, p 0.05; Fig. 6D; time in the target quadrant at 6 months:
p 0.05). Additionally, even though all groups remained above
chance in the correct quadrant (Wilcoxon signed rank test, all
p 0.05), PLB4mice were significantly impaired compared with
PLBWT at 6 months (p  0.05). Close inspection of probe trial
data suggested a trend for an age-related decline in PLBWT per-
Figure3. Habituation to a novel environment, locomotor activity, and circadian rhythms.A, Nonlinear regression analyses of activity (distancemoved, cm) during habituation to the PhenoTyper
revealed strong trends for overall genotype effect in 3-month-old PLB4mice comparedwith PLBWT ( p 0.052), with transgenic animals exhibiting heightened exploration during the initial 3 h of
habituation. Increased activity was also observed in 6- (B) and 12-month-old (C) PLB4 animals compared with age-matched PLBWT mice ( p 0.001 and p 0.05, respectively). This novelty-
induced hyperactive phenotype of transgenic subjects yielded increased tau values compared with PLBWT mice, indicating heightened exploration and delayed habituation in a new environment.
D, A robust aging effect on habitation activity was identified in PLB4mice, whereas no similar trends were noted for controls. E–G, Distance moved (cm) in hourly bins over 96 h (posthabituation)
was unaltered in PLB4 animals at 3 months, but markedly affected from 6months onward.H, Mean distancemoved (SEM) pooled for light and dark phases were decreased at 6 and 12months,
respectively; *p 0.05, ***p 0.001. Data are shown as means
 SEM.
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formance (one-tailed t test, p  0.09), whereas PLB4 mice re-
mained at a constant level matching that of 12-month-old
PLBWT.
Activity analysis revealed normal swim speeds in 6-month-old
transgenic animals but, in contrast to control subjects, no age-
dependent reduction in swim speed was observed in PLB4 mice,
resulting in a significant age effects in PLBWT only (F(1,78) 32.5;
p  0.001) as well as a significantly enhanced swim speed in
12-month-old PLB4 compared with age-matched controls
(F(1,93) 21.54, p 0.001; Fig. 6C).
A richer understanding of the behavioral anomalies expressed by
PLB4mice was obtained by categorization of each trial into specific
swimpatterns (Fig. 7).Examplesof categories aredisplayed inFigure
7Awithmatched color coding, i.e., cold colors indicatemore spatial
and warm colors more nonspatial strategies. What is evident from
the relative occurrence of each category is the natural progression in
all cohorts from15% spatially oriented swims on day 1 to	40%
onday4,whereasnonspatial strategies declinedby the sameamount
(Fig. 7B–E). PLB4micediffered reliably fromcontrols oneachdayat
both 6 and 12 months (except day 2 at 12 months; see statistical
Figure 4. Anxiety-related behaviors in the LDB and EPM. A, Although the LDBwas anxiogenic for both genotypes, transgenic animals exhibited increased time in the light box (LB) and reduced
time in the dark ‘safe’ compartment (dark box, DB) compared with controls. B, A similar trend was observed for time spent in open arms (OA) of the EPM ( p 0.08), where PLB4 mice were less
anxious than PLBWT subjects (TZ, transition zone; CA, closed arms). C, Evidence for increased locomotor activity of transgenic animals was observed in the EPM ( p 0.08), but not in the LDB (note,
distance moved was normalized to total time in LB). D, Representative activity traces from both paradigms. Data are expressed as mean SEM; *p 0.05.
Figure 5. Spatial workingmemory and spontaneous alternations of PLBWT and PLB4 animals at 3, 6, and 12months of age in Y-maze.A, Correct alternations (in%)were reduced comparedwith
PLBWTmice at 6months of age (13%) only.B, Overall effect of age, but not genotype,was identified for total number of transitionsmade,with 3-month-old animals beingmore exploratory. Data
represent means SEM; **p 0.01.
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summary in Fig. 7), caused largely by fewer directed swims (50%
reduced cf.WT)andamodest loweringof focal searches in thePLB4
groups. At the same time, PLB4 mice were slower to abstain from
wall hugging andmaintained scanning (	10%) and ultimately very
high percentage of chaining responses (35%) to solve the task
(WT: 7 and 20%, respectively). This differencewas observed at both
ages and suggests a spatial impairment already present at 6 months.
One possibility, however, is that path efficiency (E) within each ex-
clusive category may differ between genotypes (and ages) so that
random searches may be less efficient in PLB4mice than in PLBWT.
However, respective data summarized in Table 1 reveal that path
efficiency was equal in all cohorts for each trial category. From these
values, an obvious conclusion is that the modestly enhanced chain-
ing strategy over directed search or focal strategies produces a small
lossof10–15%pathefficiency; this can fullyaccount for the spatial
learning deficit observed in both PLB4 cohorts (Fig. 6A,B).
Long- and short-term semantic-like memory deficits follow
different time courses
Further characterization of cognitive phenotypes used the
semantic-like STFP task at 4 and 6 months of age (Fig. 8). Before
this task, olfactory function of transgenic animals was assessed
using the “BuriedCookie Test” (adapted fromYang andCrawley,
2009), in which hBACE1 mice exhibited normal latencies to a
hidden olfactory cue compared with control mice indicating in-
tact olfactory abilities (data not shown).
During the social interaction phase of STFP (30 min), we
detected no difference between any of the groups with regards to
their social interest in the demonstrator mouse (time in social
interaction zone, two-way ANOVA: F(1,72) 1.9; p	 0.05), and
all groups spent an average of 10 min with the demonstrator
(p	 0.05; data not shown), indicating absence of anxiety as well
as normal exploratory and social responsiveness.
During the food preference test, 4-month-old transgenic ani-
mals exhibited intact memory for the cued (presented) food in
the short-term test (15 min delay, STM) as indicated by a food
preference (72.5% in PLB4 vs 82.8% in PLBWT) significantly
above the level of chance (p 0.01). Interestingly, their residual
LTM for correct food did not differ from the level of chance
(55%, p  0.36; Fig. 8A). Hence, PLB4 mice displayed a delay-
dependent disruption in memory retrieval at 4 months. Results
Figure 6. Spatial memory of PLBWT and PLB4 animals at 6 and 12months of age in thewater maze. A,B, Mean path length for each day of testing and representative swim paths for acquisition
days and probe trial (A1–A4 with hidden platform; P: probe trial). PLB4 animals presented with a learning impairment during acquisition days at both 6 and 12 months of age. C, PLBWT controls
showed an age-induced reduction in swim speed; PLB4 animals continued to swimwith high velocity at 12months of age.D, Performance in the probe trial revealed an overall genotype effect, and
was significantly affected in 6-month-old group. Data are expressed as means
 SEM; *p 0.05, **p 0.01.
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were further supported by food consumed during the preference
test (Fig. 8B), as PLB4 mice ate more cued compared with the
novel food choice in the immediate test (p  0.05), but lacked
such a preference in the LTM test (p  0.3). Additionally, fre-
quency of visits to the jar zone appeared as an additional readout
for this phenotype (Fig. 8C; STM: p 0.055; LTM: p	 0.05).
At 6 months of age, an overall genotype difference was con-
firmed (for food preference in %), with PLB4 displaying delay-
independent deficits (F(1,83)  7.57, p  0.01; Fig. 8D).
Preference scores of 55% (STM test) and 66% (LTM test) were
obtained, both of which were significantly lower compared with
PLBWT (STM: 75% preference, p  0.05; LTM test: 88.5% pref-
erence, p 0.05) and did not differ from the level of chance. Food
intake data also suggested that PLB4 mice failed to reliably in-
crease the intake of cued compared with novel food in the imme-
diate test, whereas PLBWTdisplayed a significant preference (WT:
p  0.05; PLB4 p  0.06; Fig. 8E). Similarly, for the 24 h delay,
PLB4mice failed to display intact residual memory for cued food
(WT: p  0.001, PLB4: p  0.09). Again, food intake and fre-
quency of visits confirmed food preference scores (Fig. 8E,F).
With regard to total food intake, an age effect was detected in
both genotypes (reduced consumption at 6months cf. 4 months;
p  0.001), and food intake was reduced in PLB4 mice over the
LTM phase (p  0.01). Although reduced food intake in PLB4
Figure7. Strategy analysis ofwatermaze performance in PLB4 andPLBWT cohorts revealed striking genotype differences.A, Representative sample traces of identified swim categories and their
color codes. Mean relative occurrence of each strategy is presented for the four spatial acquisition days for PLBWT aged 6 (B) and 12 (D) months, as well as respective PLB4 cohorts (C, E). Data tables
display reliable genotype differences based on the statistical comparison of contingency plots between age-matched cohorts, with set to 5%.
Table 1. Path efficiency categorized by strategy choice
PLBWT 6 m PLBWT 12 m PLB4 6 m PLB4 12 m
Mean SEM Mean SEM Mean SEM Mean SEM ANOVA
Direct 90.2 1.4 87.9 3.8 92.7 1.8 90.5 2.5 F 1, p 0.69
Focal 42.2 3 42.3 3.5 51.1 4.6 47.7 5.2 F 1, p 0.36
Directed 53.9 2.5 49.6 3.7 50.1 4.4 51.5 3.4 F 1, p 0.80
Chaining 38.5 4 38.8 4.1 34.2 3.4 33.9 2.5 F 1, p 0.61
Scanning 29.2 4.3 21.3 2.7 29.6 4.1 28.8 2.7 F 1.3, p 0.29
Random 11.5 3.2 15.7 3.5 16.9 4 11.3 2.4 F 1, p 0.53
Wall hugging 24.2 4 15.8 2.4a 22.6 3.3 17.6 4.3 F 1, p 0.43
Overall, there was no difference between path efficiency within a given strategic category between genotypes, calculated as E (hypothetical perfect path / total recorded path) 100 yielding values between 100 (perfect trial) and 0
(platform not found). m, Months.
aReliable age effect for PLBWT (one-tailed t test).
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mice during the STFP may reflect decreased motivation to per-
form the test, further analysis indicated that the performance
level in the STFP task did not correlate with food intake, and thus
we can be confident that data expressed as preference score (in
percentage) are genuine reflection of STM and LTM.
Overall, our STFP data suggest an age-dependent deficit in
semantic-like memory in PLB4 animals, with long term retrieval
being affected earlier than short term recall.
Tissue analyses: recruitment of mAPP by hBACE1 and
resulting histopathologies
APP and -amyloid pathology
To identify and quantify AD-relevant molecular changes that
may underlie the behavioral phenotypes, and to characterize the
impact of hBACE1 expression on endogenous mouse APP me-
tabolism, Western blots were performed using whole brain solu-
ble proteins from 6- and 12-month-old mice (Fig. 9A,B). The
Figure 8. STFP test: semantic-likememory of PLBWT and PLB4 animals at 4 and 6months of age. A, Preference for cued food (in%) in 4-month-old transgenic animals was intact in the STM test
but affected in the LTM component, results did not differ from the level of chance; 50%).B, C, Amount of cued food eaten and analysis of time spent in jar zones confirmed intact semantic-like STM
and disrupted LTM in young transgenic animals.D, At 6month of age thememory for cued foodwas significantly altered in PLB4mice (with both STM and LTM scores not different to chance), with
reducedpreference in both delays comparedwith PLBWT, indicating an age-dependent reduction in semantic-like retrieval.E,F, Analysis of raw food intake data and frequency of entry into jar zones
during STM and LTM tests confirmed that only PLBWT displayed intactmemory for cued food. Data are expressed asmeans SEM; $, Indicates significantly above chance (50%); *p 0.05, **p
0.01, ***p 0.001.
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anti-mouse APP antibody recognized
proteins at molecular weights of 115
kDa, 50–56 kDa, 17 kDa, and 10 kDa, cor-
responding to full-lengthAPP, 56 kDa oli-
gomeric APP deposits (hereafter named
*56 A; Lesne´ et al., 2006, 2013), CTF-,
and CTF- membrane-retained frag-
ments, respectively. The antibody did not
detect quantifiable bands 10 kDa (i.e.,
monomeric A). Robust differences were
observed for APP metabolites samples
from 6-month-old PLBWT and PLB4
mice. Primarily, a substantial reduction of
full-length APP was seen in PLB4 brains
(29% relative to PLBWT bands at 115
kDa; p 0.05; Fig. 9C), and a concurrent
increase in accumulation of lower molec-
ular weight APP fragments in young PLB4
subjects compared with age-matched PL-
BWT mice, indicating an accelerated pro-
teolysis of endogenous APP in our
transgenic mice. Specifically, accumula-
tion of dodecameric *56 A (double
9–12-mer band) was elevated in PLB4
brain supernatants comparedwith PLBWT
(68% relative to age-matched controls,
p  0.05). Expression of the 17 kDa
CTF- fragment, a direct product of
BACE1 cleavage, was also prominently in-
creased in PLB4 forebrains (180%, p
0.001 cf. PLBWT). Intriguingly, 4 of 5 brain
lysates from 6-month-old PLB4 mice dis-
played heightened production of neuro-
protective CTF- compared with age-
matched control brains (overall p 0.05;
10 kDa band).
Analysis of 12-month PLB4 tissue
using the murine-specific anti-APP/A
antibody (Fig. 9D) also confirmed accel-
erated proteolysis of endogenous APP in
aged PLB4 brains (21% cf. controls; p  0.05), as well as ele-
vated accumulation of A*56 (62% relative to aged WT; p 
0.05) and trends for increased production of CTF- (37% cf.
WT; p  0.08). Unlike younger transgenic mice, 12-month-old
PLB4 brains did not present with elevated levels of CTF- com-
pared with controls (p 	 0.05). Analysis of relative mAPP/me-
tabolite composition (Fig. 9E) visualizes the pathological
processing of the endogenous protein in hBACE1 mice indepen-
dently of age, with 62 and 59% of mAPP available as full-length
APP in young and old PLB4 brains compared with 75 and 70% in
controls, respectively, while depositing a substantial amount of
toxic CTF- fragments and oligomeric *56 A compared with
age-matched PLBWT (6 m: 25 vs 13% in WT; 12 m: 30 vs 20% in
WT).
Two additional antibodies were used to determine the oligo-
meric A profile in hBACE1mice (6E10 andMOAB-2) and allow
for a comparison with PLB1Triple mice. Both antibodies detected
bands at 56, 27, and 12 kDa (Fig. 10A,B), corresponding to
A*56, hexameric and trimeric A (Lesne´ et al., 2006). Quanti-
fication of bands validated heightened production of A*56 in
symptomatic hBACE1 mice (2-fold increase, p  0.05), and
further revealed an increased accumulation of hexameric A in
PLB4 brains compared with controls (6E10-immunorecative
6-mer A, p  0.05; MOAB-2-immunoreactive 6-mer A, p 
0.07; Fig. 9C,D). Interestingly, A pathology in hBACE1 animals
was comparable to that of age-matched PLB1Triple mice com-
pared with WT controls. Notably, monomeric A was not de-
tected in the transgenic groups, and levels of A trimers were
unaltered compared with PLBWT. Further experiments were per-
formed to validate the 56 kDa fragment as genuine oligomeric
assemblies of A, adapted from a previously verified HFIP disag-
gregation protocol (Lesne´ et al., 2006). Levels of *56 A in PLB4
brain lysates were concentration-dependently reduced upon
HFIP application (0, 10, and 20%were used) amid a concomitant
increase in levels of monomeric amyloid peptide (	4 kDa; Fig.
10E). To determine whether monomeric A accumulated in
transgenic PLB brain tissue in the absence of depolymerizing
agents, we also immunoprecipitated soluble brain factions from
PLB4 and PLB1Triple mice with 6E10-conjugated dynabeads (Fig.
10F). Immunoprecipitated samples from PLB4 and PLB1Triple
mice presented with pronounced expression of bands corre-
sponding to oligomeric A species (12-meric *56, 6-mer, 4-mer,
and 3-mer) compared with PLBWT controls, whereas samples
from an APP/PS1 overexpression model exhibited saturated sig-
nals for full-length APP and monomeric A, but no oligomeric
Figure 9. Molecular characterization of endogenous APP/A profiles in PLB4 and control animals based on a rodent-specific
anti-APP/N-terminal antibody. A, B, Representative Western blots of 6- and 12-month-old soluble brain lysates from PLBWT and
PLB4mice The antibody recognized bands at115,56,17, and10 kDa, corresponding to full-length APP (fl APP), A*56,
CTF-, and CTF-, respectively. C,D, Quantification revealed a substantial decrease of flAPP, and a concurrent increase in expres-
sion of oligomeric A*56, and CTF in PLB4 mice compared with age-matched PLBWT brain soluble lysates at both ages. Note,
elevated levels of CTFwere only identified in 6-month-old hBACE1 soluble brain lysates comparedwith controls. E, Composition
(in%)of endogenousAPPand itsmetabolites illustrates the increasedprocessingof endogenousAPP inhBACE1mice at both6 and
12 months of age, with reductions in APP amid increased accumulation of toxic higher order A*56 oligomers and CTF-
fragments. Data were Coomassie adjusted and represent means SEM; *p 0.05, ***p 0.001.
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species. These observations cumulatively suggest levels of mono-
meric A in both PLB lines to be below the detection limit, likely
due to a favored conversion toAoligomers andoverall contrast-
ing with an APP overexpression model.
To further determine APP processing and regional A accumu-
lation in PLB4 mouse brains, immunoreactivity was quantified in
brain sections from 12-month-old animals. The anti-mouse APP
antibody did not yield specific binding in histological sections,
hence, the 6E10 antibody was used which showed specific staining
due to cross reactivity with the highly homologous mouse amyloid
sequence (Fig. 11A).
Significantly enhancedAPP/amyloid somatic stainingwas ob-
served in PLB4 tissue relative toWT’s in both hippocampal areas
(Fig. 11B, intracellular), i.e., PLB4 animals exhibited significantly
more 6E10-positive cells in CA1 and DG compared with PLBWT
(both p 0.001). Elevated extraneuronal accumulation was also
evident in areas CA1 (p  0.01) and DG (p  0.05), alongside
respective trends in cortex (p 0.06). Consequently, only intra-
cellular occurrence of APP/A showed some region-specificity,
whereas extracellular amyloid accumulation was more broadly
increased in aged PLB4 forebrains compared with controls.
Although pronounced APP/A accumulation surrounding
neuronal somata was observed, 6E10-positive plaques were
sparse (5–8 per section, Fig. 11C) and generally small. Never-
theless, prominent extracellular staining was also identified in
other PLB4 forebrain areas, including neurons in fiber track ram-
ifications (lower lateral corpus callosum; Fig. 11D), often sur-
rounding cell bodies undergoing nuclear inclusions (Fig. 11E,F).
Degenerated neurones with residual cytoplasmic constituents
were rarely observed inWT tissue but prominent and frequent in
transgenic brains (Fig. 11F).
Preliminary analyses of putative changes in tau or phopho-tau
expression provided no reliable evidence for abnormal phos-
phorylation or conformational changes of endogenous tau in
PLB4mice, only trends were observed for an increase of total tau
levels at 6 months of age (data not shown).
Figure 10. Detailed screening of oligomeric A in 6-month-old hBACE1 knock-in mice as well as a comparison with the targeted knock-in PLB1Triple mouse and a pronuclear injection-derived
APP/PS1mouse. A, B, RepresentativeWestern blots of soluble brain lysates from PLBWT, PLB4, and PLB1Triple mice, stained with the 6E10 (A) antibody and the oligomer-specific MOAB-2 antibody
(B), detecting A*56, hexameric, and trimeric A. C,D, Quantification of 6E10 andMOAB-2 immunoreactivity validated themarked increases in A*56 accumulation in PLB4mice comparedwith
PLBWT controls, and further uncovered theheightenedoccurrence of hexameric A (27 kDa). Trimeric Adid not differ in hBACE1 knock-inmice comparedwithWTat 6months of age. Interestingly,
the twoPLB lines showed comparable levels of oligomeric species.E, HFIP-induceddisaggregationof oligomericA species inPLB4brain lysates. Expressionof dodecameric *56and lowermolecular
weight A assemblies including themonomeric formwasHFIP concentration-dependent. F, 6E10-IP brain lysates fromPLB4 andPLB1Triplemice exhibited pronounced expression of A*56, 6-mer,
and 3-mer A compared with PLBWT controls, whereas pronuclear injection-derived the APP/PS1 sample presented with bands corresponding to monomeric A and full-length APP (flAPP) only.
Monomeric Awas not detected in transgenic PLB brain lysates even upon IP, suggesting that A favors an oligomeric state. H, Depleted homogenate; S, supernatant. All Western blot data were
normalized to Coomassie and expressed relative to appropriate WT controls. Data represent means SEM; *p 0.05, **p 0.01.
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Gliosis and inflammation
Additional histopathological changes were investigated with re-
gards to putative astrocyte activation as a marker for inflamma-
tory reactions due to hBACE1 knock-in and APP pathology at 12
months of age for several AD- and cognition-relevant brain areas.
Accelerated inflammation was identified in PLB4 brain tissue
(Fig. 12A,B), in a region-specific and genotype-dependent man-
ner. Highest levels of astrogliosis were encountered within the
DG (p 0.001), but levels were also significantly higher in hip-
pocampal CA1 (p  0.05) and piriform cortex (p  0.01, Pir),
whereas only trends were observedwithin the parietal association
area and amygdala (p  0.08 and p  0.09, for PtA and Am,
respectively).
Finally, we investigated whether levels of inflammation corre-
lated with cognitive performance, i.e., by separating histological
data from good and bad PLB4 learners (based on performance in
theOFWM). Planned paired comparison indicated thatWTmice
differed substantially from bad learners due to differences in DG
(p 0.0001), Pir (p 0.001), and Am (p 0.01), whereas good
learners differed significantly only in the DG (p 0.001). Com-
paring good and bad learners within the PLB4 cohorts further
corroborated the link between inflammation and learning per-
formance (two-way ANOVA, performance and brain area as fac-
tors; F(1,55)  13.82, p  0.001; Fig. 12C), with bad learners
exhibiting substantially stronger GFAP staining compared with
good learners; both parietal association cortex (PtA, p  0.001)
andCA1 (p 0.05) displayed significantlymore inflammation in
bad learners compared with good learners. Hence, DG inflam-
mation common to both groups did not contribute to the learn-
ing phenotype.
Discussion
BACE1 activity is recognized as the rate limiting step in the patho-
logical processing of APP (Ahmed et al., 2010) and several attempts
have been made to characterize its function in vivo. To date, results
from four mouse models overexpressing hbace1, all generated via
pronuclear injection techniques, have been reported. These were
primarily designed to create app  bace1 double-transgenic lines,
AD-relevant behavioral phenotypes andunderlying cellular changes
were not assessed in detail. The first line (overexpression 4- to 10-
fold cf. wild types) was developed by Harrison et al. (2003), who
characterized basic behaviors (SHIRPA screen) and neurochemical
changes (BACE expression and CTFs), but phenotypic assessments
didnot investigateAD-relevant behaviors andbiochemicalmarkers.
Similarly, other models generated via pronuclear injection reported
acceleratedAPPprocessingbasedonCTFanalyses (Bodendorf et al.,
2002) and increased amyloid deposition when crossed with app-
expressing mice (Chiocco et al., 2004; Mohajeri et al., 2004), thus
demonstrating that coexpression of hBACE1 significantly exacer-
bates hAPP processing and A production. Together, these reports
didnot establishhBACE1actions in the absence of humanAPP, and
whether this is sufficient to induce amyloidosis andAD-related phe-
notypes in mice.
Here, we report that knock-in and subtle expression of hbace1
led to a compelling age- and task-dependent phenotype in the
absence of hAPP (over)expression, resembling many aspects of
human AD. Southern blots, Western blots, and immunohisto-
chemical analyses confirmed hBACE1 expression profiles, with
approximately twofold protein levels comparedwith endogenous
mouse BACE1; BACE1-positve neurones were particularly fre-
quent in cortical and hippocampal areas.
Figure 11. Immunocytochemical characterization of APP/A accumulation in 12-month-old PLBWT and PLB4 brain tissue (6E10 staining). A, Representative histological images of accelerated
amyloid pathology in brains of old mice overexpressing hBACE1 (n 4 per group). Strong immunoreactivity to 6E10, associated with hippocampal (CA1 and DG) and cortical (CTX) neurones were
found in PLB4mice. The scale bar indicates 100m.B, Quantification of intracellular and extracellular A accumulation revealed a significant increase in the brains of transgenic animals compared
with control group. Data (meansSEM)were normalized toWT. PLB4 brain tissue exhibited infrequent amyloid plaques (C), prominent intra- and extra-neuronal APP/A occurrence in fiber tracts
(D), and numerous neuronal inclusions in hippocampal areas (E, F). Scale bar: C, 400m; D–F, 40m. Asterisks show differences to controls; *p 0.05, **p 0.01, ***p 0.001.
10724 • J. Neurosci., August 6, 2014 • 34(32):10710–10728 Plucin´ska et al. • Human BACE Knock-In Reiterates Alzheimer’s
Behavioral profile of hBACE1 knock-in mice
Phenotyping comprised physiological, motor, activity-related,
and emotional aspects. No overt health effects were observed,
PLB4 mice presented with an age-dependent weight reduction
compared with controls from 6 months onward (predominantly
in males). Conventional hyperexpression of bace1 caused body
weight loss as early as 7 weeks old (Harrison et al., 2003); some-
what contradictory, body weight reductions have also been de-
scribed for bace1 knock-out mice alongside protection against
high-fat diet induced obesity (Meakin et al., 2012). BACE1 there-
fore seems to contribute to metabolic regulation; nevertheless,
this phenotype had only minor consequences since sensory and
motor functions were overall intact. Circadian activity patterns
were also not altered in PLB4mice; yet, motor activity was mark-
edly decreased at 6 and 12 but not 3months. By contrast, novelty-
induced ambulation was extended during habituation; this
phenotype already occurred at 3 months and became progres-
sively more severe, providing strong evidence for impaired for-
mation of spatial representations in PLB4 subjects. Interestingly,
APP-based models of amyloidosis also presented with slowed
habituation combined with hyperactivity (Deacon et al., 2009;
Walker et al., 2011). It is unlikely that prolonged habituation was
due to stress or anxiety because both previous hBACE models
(Harrison et al., 2003) and PLB4 mice presented with reduced
anxiety-related behavior.
Further evidence for cognitive and spatial deficits was pro-
vided in the Y-maze (spatial workingmemory), watermaze (spa-
tial learning and reference memory), and STFP (semantic STM
and LTM). Impairments in the Y-maze at 6 months are in line
with the attributed role of amyloid (for review, see Lalonde et al.,
2012). Working memory deficits were not detected in older PLB4
mice due to a significant aging effect in PLBWT animals. In thewater
maze paradigm, widely used to examine spatial navigation perfor-
mance inADmousemodels (Stewart et al., 2011; Platt et al., 2011), a
spatial acquisitiondeficitwas apparent inPLB4mice at 6months.At
12 months, PLB4mice continued to display impaired spatial learn-
ing yet no longer differed fromWTs in recall, again due to reduced
performanceof the control group. In linewith this, heightened levels
of hBACE1 protein expression did not accelerate from 6 to 12
monthsof age inPLB4 forebrains; however, post-translationalmod-
ifications and protein handling may well be affected, as strongly in-
dicated by pathological APP processing, accompanied by elevated
neuroinflammation in 12-month-old hbace1KImice.We observed
themost reliable AD-relevant phenotypes with a clearest separation
of controls and transgenic mice at 6 months of age, suggesting that
introduction of hbace1 resulted in premature aging in PLB4mice. A
comparison with the PLB1Triple mouse generated via identical
knock-in, uncovered that introduction of hbace1with a comparable
expression profile had amore profound impact, i.e., PLB1Triplemice
were only impaired from 12 months (Platt et al., 2011; Ryan et al.,
2013). Deficits in spatial learning are common in transgenic APP
mice (Stewart et al., 2011), and have been attributed to a loss of
spatial learning strategies (Janus, 2004; Brody andHoltzman, 2006).
Intriguingly, both TgCRND8mice and PSAPPmice, like PLB4, also
increased the amount of chaining and random exploration trials.
Further characterization of cognitive phenotypes used a
semantic-like STFP task that relies on nonspatial, socially
acquired olfactory information. PLB4 mice displayed unaltered
Figure 12. Regional expression and quantification of GFAP-labeled astrocytic cells at 12months of age. A, Representative confocal images of active astrocytes (red) in subcortical (CA1, DG, Am)
and cortical areas (PtA, Pir) fromWTand PLB4 tissue.B, GFAP expressionwas2-fold (CA1, PtA) and3-fold higher (DG) in PLB4 brain tissue comparedwith age-matched control group. C, Brains
fromPLB4micewith severe cognitive impairment (behaviorally assessed inwatermaze)presentedwith thehighest levels of astrogliosis comparedwithPLBWTmice. Scalebar, 50m.Magnification
63. Asterisks indicate difference to control group; *p 0.05, **p 0.01, ***p 0.001. All data were normalized to WT and represent meansSEM.
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sociability, however, significant genotype- and age-related differ-
ences were observed during the discrimination task. Young PLB4
animals showed intact STM, but failed during LTM testing, i.e.,
the task with the high memory load. At 6 months, transgenic
cohorts failed in both components thus confirming progressive
deficits. Overall, this additional facet of cognitive impairment
somewhat resembles a deficit described in 18-month-old 3xTg
mice (Cassano et al., 2011), unfortunately no STFP data are avail-
able from other AD cohorts. The semantic deficit cannot be at-
tributed to an olfactory loss described in Tg2576mice (Wesson et
al., 2010), as the “cookie test” was unaffected. STFP thus offer a
species-adequate and convenient paradigm with close face valid-
ity, because semantic memory deficits are well documented in
mild cognitive impairment patients (Venneri et al., 2008) and
correlate with perirhinal/entorhinal as well hippocampal MRI
phenotypes (Barbeau et al., 2012; Hirni et al., 2013).
Molecular and immunocytochemical characterization of
human BACE1 knock-in mouse
In agreement with previous BACE1 models (Bodendorf et al.,
2002; Mohajeri et al., 2004), we demonstrated that hbace1
knock-in induces pathologic processing of murine APP, with de-
creased full-length APP and heightened CTF fragments, but
also increased levels of the toxic A*56 and hexameric A assem-
blies, whereas mature and aggregated A plaques were sparse.
Therefore, low levels of hBACE1 expression are sufficient to
cause formation of A oligomeric assemblies, mainly A*56 pre-
viously proposed as the most toxic form suggested to correlate
with emergence of memory impairments in transgenic mice (Le-
sne´ et al., 2006, Billings et al., 2007) and in human AD (Lesne´ et
al., 2013). Moreover, immunohistochemistry revealed strong
anti-APP/A immunoreactivity in hippocampal regions. Intra-
cellular accumulation was particularly pronounced in CA1 and
DG, this may be caused by lack of secretion of generated A and
its subsequent accumulation. Alternatively, released A may be
reabsorbed by neurons and stored in intracellular pools (Kane-
kiyo et al., 2013). Although the physiological or pathophysiolog-
ical role of intraneuronal APP/A is not fully understood,
evidence suggests that intraneuronal A accumulation occurs in
brain areas affected in early human AD pathology, such as the
hippocampus and entorhinal cortex (Gouras et al., 2000). In
transgenic models, intraneuronal accumulation of A precedes
the formation of extracellular amyloid plaques and is likely to
cause neurodegeneration (for review, see Bayer and Wirths,
2010). More importantly however, A readily aggregates into
multimeric forms, a process initiated within the cells rather than
in the extracellular space (Walsh et al., 2000). Future studies will
confirm the exact identity of (toxic) intraneuronal amyloid spe-
cies, with for example modified amyloid species (e.g., pyroglut-
mate or phosphorylated A) proposed as putative toxic
molecular entities (Kumar et al., 2013).
Despite the paucity of plaques, extracellular emergence of
APP/A was reliably detected surrounding neuronal cell bodies
throughout the forebrain of PLB4 mice. Extracellular A accu-
mulation is not essential for AD-like phenotypes (Ghosal et al.,
2009) andmay be inversely correlated to the build-up of intracel-
lular A (Bahr et al., 1998;Oddo et al., 2006). In PLB4 hippocam-
pal neurons, intense staining was present inside and surrounding
neurones and frequent cell inclusions were detected. While this
has not been investigated in detail, inclusions are indicative of
apoptotic processes and were often surrounded by heavy extra-
cellular A staining. Subcellular pathologies may reflect mi-
crodomains relevant for sorting and trafficking of APP/ A and
BACE, andmay play a crucial part in degenerative pathways (Das
et al., 2013; Walter and van Echten-Deckert, 2013).
Further biochemical changes observed in PLB4 brain tissue
related to GFAP levels (astrogliosis). We detected GFAP activa-
tion in hippocampal and cortical regions of PLB4 brains, withDG
most strongly affected, thus matching the area of most intense
hBACE immunoreactivity. The piriform cortex, responsible for
olfactory information processing and memory, was also mark-
edly inflamed, a putative cellular correlate for deficits observed in
STFP. As brains were harvested from animals tested in OFWM,
we divide tissue into good and bad learners based on their behav-
ioral performance. A robust association between “learning phe-
notype” and the level of astrogliosis was identified, with CA1, and
PtA and Pir cortices affected only in bad learners, labeling in DG
was independent of cognitive scores. These findings are consis-
tent with accumulation of APP/A in CA1 andDGof PLB4 brain
tissue and suggest that levels of brain inflammation particularly
in CA1 and cortical areas (rather than DG) correspond to cogni-
tive deficits more accurately than i.e., amyloid plaque load.
In conclusion, this report is the first to comprehensively iden-
tify AD-relevant behavioral traits produced by hbace1 knock-in.
Our results confirm that subtle hBACE1 expression is sufficient
to recapitulate key aspects of human AD in mice, this was poten-
tially overlooked in previous studies due to lack of plaque forma-
tion.We propose that the PLB4mousemodel not only provides a
better understanding of BACE’s physiological and pathophysio-
logical roles, it also likely offers better face- and predictive-
validity for therapeutic intervention.
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